KAREN RABIN to Nitriles
This is a "connection" page, showing publications KAREN RABIN has written about Nitriles.
Connection Strength
0.022
-
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011). Pediatr Blood Cancer. 2015 Oct; 62(10):1717-24.
Score: 0.022